Phase 2, randomized, dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemia

David S. Krause, John Reinhardt, Jose A. Vazquez, Annette Reboli, Beth P. Goldstein, Michele Wible, Timothy Henkel

Research output: Contribution to journalArticlepeer-review

155 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 2, randomized, dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemia'. Together they form a unique fingerprint.

Medicine & Life Sciences